Pulmonary hypertension: Pathology

Handbook of Experimental Pharmacology

Volumn 218, Issue , 2013, Pages 59-75

  Dorfmüller, Peter ^a,b  

^a CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^b Universite Paris Sud   (France)

Author keywords

Histology; Intimal fibrosis; Medial hypertrophy; Plexiform lesion; Pulmonary hypertension; Pulmonary veno occlusive disease

Indexed keywords

AORTA ATHEROSCLEROSIS; ARTERY INTIMA PROLIFERATION; ARTERY LESION; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL HYPERPLASIA; CELL PROLIFERATION; CONNECTIVE TISSUE DISEASE; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FIBROBLAST; FIBROSIS; HISTOLOGY; HUMAN; HYPERTROPHY; HYPOXIA; INTIMAL FIBROSIS; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; LUNG VASCULAR RESISTANCE; MEDIAL HYPERTROPHY; MYOFIBROBLAST; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY CAPILLARY HEMANGIOMATOSIS; PULMONARY HYPERTENSION; PULMONARY VENO-OCCLUSIVE DISEASE; SMOOTH MUSCLE FIBER; THROMBOSIS; VASCULITIS;

ANIMALS; CONNECTIVE TISSUE DISEASES; FIBROSIS; HUMANS; HYPERTENSION, PULMONARY; HYPERTROPHY; PULMONARY ARTERY; PULMONARY VENO-OCCLUSIVE DISEASE;

EID: 84893123086     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-642-38664-0-3     Document Type: Article

References (55)

1. Aloisi F, Pujol-Borrell R (2006) Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 6(3):205-217
2. Badesch DB, Tapson VF, McGoon MD, Brundage BH, Rubin LJ, Wigley FM, Rich S, Barst RJ, Barrett PS, Kral KM, Jobsis MM, Loyd JE, Murali S, Frost A, Girgis R, Bourge RC, Ralph DD, Elliott CG, Hill NS, Langleben D, Schilz RJ, McLaughlin VV, Robbins IM, Groves BM, Shapiro S, Medsger TA (2000) Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med 132(6):425-434
3. Balabanian K, Foussat A, Dorfmuller P, Durand-Gasselin I, Capel F, Bouchet-Delbos L, Portier A, Marfaing-Koka A, Krzysiek R, Rimaniol A, Simonneau G, Emilie D, Humbert M (2002) CX (3)C chemokine fractalkine in pulmonary arterial hypertension. Am J Respir Crit Care Med 165(10):1419-1425
4. Capron F (1999) Bronchoalveolar lavage and alveolar hemorrhage. Ann Pathol 19(5):395-400
5. Carragher DM, Rangel-Moreno J, Randall TD (2008) Ectopic lymphoid tissues and local immunity. Semin Immunol 20(1):26-42
6. Cool C, Kennedy D, Voelkel N, Tuder R (1997) Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. Hum Pathol 28(4):434-442
7. Cool CD, Stewart JS, Werahera P, Miller GJ, Williams RL, Voelkel NF, Tuder RM (1999) Threedimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol 155(2):411-419
8. Di Biase L, Fahmy TS, Wazni OM, Bai R, Patel D, Lakkireddy D, Cummings JE, Schweikert RA, Burkhardt JD, Elayi CS, Kanj M, Popova L, Prasad S, Martin DO, Prieto L, Saliba W, Tchou P, Arruda M, Natale A (2006) Pulmonary vein total occlusion following catheter ablation for atrial fibrillation: Clinical implications after long-term follow-up. J Am Coll Cardiol 48 (12):2493-2499
9. Dib H, Tamby MC, Bussone G, Regent A, Berezné A, Lafine C, Broussard C, Simonneau G, Guillevin L, Witko-Sarsat V, Humbert M, Mouthon L (2012) Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma. Eur Respir J 39(6):1405-1414
10. Dorfmuller P, Humbert M (2012) Progress in pulmonary arterial hypertension pathology: Relighting a torch inside the tunnel. Am J Respir Crit Care Med 186(3):210-212
11. Dorfmuller P, Zarka V, Durand-Gasselin I, Monti G, Balabanian K, Garcia G, Capron F, Coulomb-Lhermine A, Marfaing-Koka A, Simonneau G, Emilie D, Humbert M (2002) Chemokine RANTES in severe pulmonary arterial hypertension. Am J Respir Crit Care Med 165 (4):534-539
12. Dorfmuller P, Perros F, Balabanian K, Humbert M (2003) Inflammation in pulmonary arterial hypertension. Eur Respir J 22(2):358-363
13. Dorfmuller P, Humbert M, Capron F, Mu ller KM (2003) Pathology and aspects of pathogenesis in pulmonary arterial hypertension. Sarcoidosis Vasc Diffuse Lung Dis 20(1):9-19
14. Dorfmuller P, Humbert M, Perros F, Sanchez O, Simonneau G, Muller KM, Capron F (2007) Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 38(6):893-902
15. Golde DW, Drew WL, Klein HZ, Finley TN, Cline MJ (1975) Occult pulmonary haemorrhage in leukaemia. Br Med J 2(5964):166-168
16. Hachulla E, Gressin V, Guillevin L, Carpentier P, Diot E, Sibilia J, Kahan A, Cabane J, Francès C, Launay D, Mouthon L, Allanore Y, Tiev KP, Clerson P, de Groote P, Humbert M (2005) Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study. Arthritis Rheum 52(12):3792-3800
17. Harrison CV (1958) IV. The pathology of the pulmonary vessels in pulmonary hypertension. Br J Radiol 31(364):217-226
18. Heath D, Edwards JE (1958) The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 18(4 Part 1):533-547
19. Heath D, Williams D (1989) High-altitude medicine and pathology. Butterworths, London
20. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Paré PD (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350(26):2645-2653
21. Humbert M, Simonneau G (2005) Drug Insight: Endothelin-receptor antagonists for pulmonary arterial hypertension in systemic rheumatic diseases. Nat Clin Pract Rheumatol 1(2):93-101
22. Humbert M, Sanchez O, Fartoukh M, Jagot JL, Le Gall C, Sitbon O, Parent F, Simonneau G (1999) Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: Results of a pilot study. Eur Respir J 13(6):1351-1356
23. Krowka MJ, EdwardsWD(2000) A spectrum of pulmonary vascular pathology in portopulmonary hypertension. Liver Transpl 6(2):241-242
24. Kucsko L (1953) Arteriovenous communications in the human lung and their functional significance. Frankf Z Pathol 64(1):54-83
25. Lantuéjoul S, Sheppard MN, Corrin B, Burke MM, Nicholson AG (2006) Pulmonary venoocclusive disease and pulmonary capillary hemangiomatosis: A clinicopathologic study of 35 cases. Am J Surg Pathol 30(7):850-857
26. Lee SD, Shroyer KR, Markham NE, Cool CD, Voelkel NF, Tuder RM (1998) Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest 101(5):927-934
27. Mandel J, Mark EJ, Hales CA (2000) Pulmonary veno-occlusive disease. Am J Respir Crit Care Med 162(5):1964-1973
28. Moser KM, Bloor CM (1993) Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest 103(3):685-692
29. Overbeek MJ, Vonk MC, Boonstra A, Voskuyl AE, Vonk-Noordegraaf A, Smit EF, Dijkmans BA, Postmus PE, Mooi WJ, Heijdra Y, Grunberg K (2009) Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: A distinctive vasculopathy. Eur Respir J 34(2):371-379
30. Penaloza D, Arias-Stella J (2007) The heart and pulmonary circulation at high altitudes: Healthy highlanders and chronic mountain sickness. Circulation 115(9):1132-1146
31. Perros F, Dorfmuller P, Souza R, Durand-Gasselin I, Godot V, Capel F, Adnot S, Eddahibi S, Mazmanian M, Fadel E, Hervé P, Simonneau G, Emilie D, Humbert M (2007) Fractalkineinduced smooth muscle cell proliferation in pulmonary hypertension. Eur Respir J 29 (5):937-943
32. Perros F, Dorfmu ller P, Montani D, Hammad H, Waelput W, Girerd B, Raymond N, Mercier O, Mussot S, Cohen-Kaminsky S, Humbert M, Lambrecht BN (2012) Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 185 (3):311-321
33. Piazza G, Goldhaber SZ (2011) Chronic thromboembolic pulmonary hypertension. N Engl J Med 364(4):351-360
34. Pietra G (1997) Pathology of primary pulmonary hypertension. Marcel Dekker, New York
35. Pietra GG, Capron F, Stewart S, Leone O, Humbert M, Robbins IM, Reid LM, Tuder RM (2004) Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 43 (12 Suppl S):25S-32S
36. Ramirez A, Varga J (2004) Pulmonary arterial hypertension in systemic sclerosis: Clinical manifestations, pathophysiology, evaluation, and management. Treat Respir Med 3 (6):339-352
37. Rangel-Moreno J, Carragher DM, de la Luz Garcia-Hernandez M, Hwang JY, Kusser K, Hartson L, Kolls JK, Khader SA, Randall TD (2011) The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat Immunol 12(7):639-646
38. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SK (1987) Primary pulmonary hypertension. A national prospective study. Ann Intern Med 107(2):216-223
39. Sakao S, Tatsumi K, Voelkel NF (2010) Reversible or irreversible remodeling in pulmonary arterial hypertension. Am J Respir Cell Mol Biol 43(6):629-634
40. Saldana ME, Harley RA, Liebow AA, Carrington CB (1968) Experimental extreme pulmonary hypertension and vascular disease in relation to polycythemia. Am J Pathol 52(5):935-981
41. Sanchez O, Humbert M, Sitbon O, Simonneau G (1999) Treatment of pulmonary hypertension secondary to connective tissue diseases. Thorax 54(3):273-277
42. Sanchez O, Marcos E, Perros F, Fadel E, Tu L, Humbert M, Dartevelle P, Simonneau G, Adnot S, Eddahibi S (2007) Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 176(10):1041-1047
43. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghetti M, Rich S, Fishman A (2004) Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43(12):5S-12S
44. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R (2009) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54(1):S43-S54
45. Stacher E, Graham BB, Hunt JM, Gandjeva A, Groshong SD, McLaughlin VV, Jessup M, Grizzle WE, Aldred MA, Cool CD, Tuder RM (2012) Modern age pathology of pulmonary arterial hypertension. Am J Respir Crit Care Med 186(3):261-272
46. Tamby MC, Chanseaud Y, Humbert M, Fermanian J, Guilpain P, Garcia-de-la-Pena-Lefebvre P, Brunet S, Servettaz A, Weill B, Simonneau G, Guillevin L, Boissier MC, Mouthon L (2005) Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension. Thorax 60(9):765-772
47. Terrier B, Tamby MC, Camoin L, Guilpain P, Broussard C, Bussone G, Yaci A, Hotellier F, Simonneau G, Guillevin L, Humbert M, Mouthon L (2008) Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension. Am J Respir Crit Care Med 177 (10):1128-1134
48. Tuder R, Groves B, Badesch D, Voelkel N (1994) Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 144 (2):275-285
49. Tuder RM, Abman SH, Braun T, Capron F, Stevens T, Thistlethwaite PA, Haworth SG (2009) Development and pathology of pulmonary hypertension. J Am Coll Cardiol 54(1 Suppl):S3-S9
50. Ungerer RG, Tashkin DP, Furst D, Clements PJ, Gong H, Bein M, Smith JW, Roberts N, Cabeen W (1983) Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med 75(1):65-74
51. Voelkel NF, Tuder RM (1995) Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension. Eur Respir J 8(12):2129-2138
52. Wagenvoort C, Wagenvoort N (1970) Primary pulmonary hypertension: A pathologic study of the lung vessels in 156 clinically diagnosed cases. Circulation 42(6):1163-1184
53. Wagenvoort CA, Beetstra A, Spijker J (1978) Capillary haemangiomatosis of the lungs. Histopathology 2(6):401-406
54. Widgren S (1986) Prolonged survey of cases of pulmonary hypertension in relation to consumption of aminorex. Histological, quantitative and morphometric study of 9 cases. Schweiz Med Wochenschr 116(27-28):918-924
55. Yaginuma G, Mohri H, Takahashi T (1990) Distribution of arterial lesions and collateral pathways in the pulmonary hypertension of congenital heart disease: A computer aided reconstruction study. Thorax 45(8):586-590